Semaglutide (GLP‐1 receptor agonist) stimulates browning on subcutaneous fat adipocytes and mitigates inflammation and endoplasmic reticulum stress in visceral fat adipocytes of obese mice

Semaglutide (GLP‐1 agonist) was approved for treating obesity. Although the effects on weight loss and metabolism are known, the responses of adipocytes to semaglutide are yet limited. C57BL/6 male mice (n = 20/group) were fed a control diet (C) or a high‐fat (HF) diet for 16 weeks and then separate...

Full description

Saved in:
Bibliographic Details
Published inCell biochemistry and function Vol. 40; no. 8; pp. 903 - 913
Main Authors Martins, Fabiane F., Marinho, Thatiany S., Cardoso, Luiz E. M., Barbosa‐da‐Silva, Sandra, Souza‐Mello, Vanessa, Aguila, Marcia B., Mandarim‐de‐Lacerda, Carlos A.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.12.2022
Subjects
Online AccessGet full text

Cover

Loading…